Cellaria Competitors and Similar CompaniesClear all

Cellaria's competitors and similar companies include Corcept Therapeutics, Kronos Bio, Adimab and Massive Genomics.

	Cellaria Cellaria is a company creating next generation in vitro disease models that reflect the nature of a patient’s biology.	Corcept Therapeutics Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators.	Kronos Bio Kronos Bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets.	Adimab Adimab is a biotechnology company that provides a discovery platform functioning as a synthetic human immune system.	Massive Genomics Massive Genomics is a company that provides genomic analysis services.
Founding Date	Founding Date 2013	Founding Date 1998	Founding Date 2017	Founding Date 2007	Founding Date 2016
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech clinical research life sciences oncology	Tags Healthcare biotech clinical research drug development	Tags Healthcare biotech clinical research life sciences oncology therapy	Tags Healthcare biotech clinical research drug development life sciences oncology	Tags Healthcare biotech clinical research genetics life sciences oncology
Locations	Locations Boxford, US HQ Wakefield, US	Locations Redwood City, US HQ	Locations San Mateo, US HQ Cambridge, US Cambridge, US	Locations Lebanon, US HQ	Locations Nairobi, KE HQ
Employees	Employees 3	Employees 50042% increase	Employees 45	Employees 1384% increase	Employees 1
Valuation ($)	Valuation ($) N/A	Valuation ($) 5 b	Valuation ($) 59.1 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $761.4m (FY, 2025)	Revenue (est.) $9.8m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income N/A	Net income $99.7m (FY, 2025)	Net income ($86.1m) (FY, 2024)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 80.1m	Total funding raised $ 271m	Total funding raised $ 45.3m	Total funding raised N/A